Status:

COMPLETED

Kisspeptin/GPR54 Pathway and Early Puberty

Lead Sponsor:

Shenzhen Center for Disease Control and Prevention

Conditions:

Puberty, Precocious

Eligibility:

FEMALE

7-10 years

Brief Summary

There was a worldwide early trend in girls'age for puberty onset. The timing of puberty onset varies greatly among individuals, and much of this variation is modulated by genetic factors. This study w...

Eligibility Criteria

Inclusion

  • \- Clinical diagnosis of central precocious puberty or early and fast puberty.

Exclusion

  • The participants who were not the first visit to the hospital and had been treated before.
  • The participants who were with endocrine disorders.

Key Trial Info

Start Date :

September 1 2016

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

July 4 2019

Estimated Enrollment :

628 Patients enrolled

Trial Details

Trial ID

NCT04012632

Start Date

September 1 2016

End Date

July 4 2019

Last Update

July 11 2019

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

Kisspeptin/GPR54 Pathway and Early Puberty | DecenTrialz